{"id":3524,"date":"2025-09-05T16:39:22","date_gmt":"2025-09-05T07:39:22","guid":{"rendered":"https:\/\/atlas.ncc.go.jp\/member_search\/3524"},"modified":"2025-09-05T16:39:22","modified_gmt":"2025-09-05T07:39:22","slug":"%e5%b0%8f%e6%9e%97%e3%80%80%e7%a5%a5%e4%b9%85","status":"publish","type":"researcher","link":"https:\/\/atlas.ncc.go.jp\/en\/member_search\/3524","title":{"rendered":"Yoshihisa Kobayashi EN"},"template":"","class_list":["post-3524","researcher","type-researcher","status-publish","hentry","en-US"],"acf":{"name_eg":"Yoshihisa Kobayashi","familyName_eg":"Kobayashi","has_jp_name":true,"name_jp":"\u5c0f\u6797\u3000\u7965\u4e45","researcher_photo":952,"participated_in":["1"],"degree":"MD, PhD","position":"Division of Molecular Pathology, Scientist","eg_position":"Division of Molecular Pathology, Scientist","facilities":3398,"department":[],"speciality":"","eg_speciality":"","background":"<h2><strong>Dr. KOBAYASHI's Story<\/strong><\/h2>\r\n<p>Dr. Kobayashi graduated with his MD from Mie University in 2008 and completed residency at Iizuka Hospital. He worked as a thoracic surgeon at Aichi Cancer Center (2010-2014) and Kindai University (2014-2018). He completed his PhD in 2017 with projects on EGFR-mutant lung cancer. He joined Pasi Janne lab at Dana-Farber Cancer Institute as a research fellow in 2018 and investigated projects on drug resistance in EGFR mutant lung cancer and novel RAS-targeted therapy. He moved to Division of Molecular Pathology at National Cancer Center Research Institute as a scientist in 2021 and continues basic and translational research for the treatment of patients with cancer.<\/p>\r\n<h2><strong>Research Interest<\/strong><\/h2>\r\n<p>Research on drug resistance and novel theapy by uncovering the underlying mechanisms of cancer biology<\/p>\r\n<h2><strong>Speciality Field<\/strong><\/h2>\r\n<p>Division of Molecular Pathology<\/p>\r\n<h2><strong>Qualifications<\/strong><\/h2>\r\n<p>Board certified general thoracic surgeon and Councilor (The Japanese Association for Chest Surgery), Board certified surgeon (Japan Surgical society), Councilor (Nucleic Acids Therapeutics Society of Japan)<\/p>\r\n<h2><strong>Professional Experience<\/strong><\/h2>\r\n<table class=\"table1\" style=\"border-collapse: collapse; width: 100%; height: 144px;\">\r\n<tbody>\r\n<tr style=\"height: 48px;\">\r\n<td style=\"width: 19.0655%; height: 48px;\">2021.1-present<\/td>\r\n<td style=\"width: 80.9345%; height: 48px;\">Scientist, Division of Molecular Pathology at National Cancer Center Research Institute<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 19.0655%; height: 24px;\">2018.4-2020.12<\/td>\r\n<td style=\"width: 80.9345%; height: 24px;\">Research Fellow, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 19.0655%; height: 24px;\">2014.4-2018.3<\/td>\r\n<td style=\"width: 80.9345%; height: 24px;\">Assistant professor, Department of Thoracic Surgery, Kindai University Faculty of Medicine<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 19.0655%; height: 24px;\">2010.4-2014.3<\/td>\r\n<td style=\"width: 80.9345%; height: 24px;\">Resident\/ Senior resident, Department of Thoracic Surgery, Aichi Cancer Center<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 19.0655%; height: 24px;\">2008.4-2010.3<\/td>\r\n<td style=\"width: 80.9345%; height: 24px;\">Resident, Iizuka hospital<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<h2><br \/>\r\n<br \/>\r\n<\/h2>","eg_background":"<h2><strong>Dr. KOBAYASHI's Story<\/strong><\/h2>\r\n<p>Dr. Kobayashi graduated with his MD from Mie University in 2008 and completed residency at Iizuka Hospital. He worked as a thoracic surgeon at Aichi Cancer Center (2010-2014) and Kindai University (2014-2018). He completed his PhD in 2017 with projects on EGFR-mutant lung cancer. He joined Pasi Janne lab at Dana-Farber Cancer Institute as a research fellow in 2018 and investigated projects on drug resistance in EGFR mutant lung cancer and novel RAS-targeted therapy. He moved to Division of Molecular Pathology at National Cancer Center Research Institute as a scientist in 2021 and continues basic and translational research for the treatment of patients with cancer.<\/p>\r\n<h2><strong>Research Interest<\/strong><\/h2>\r\n<p>Research on drug resistance and novel theapy by uncovering the underlying mechanisms of cancer biology<\/p>\r\n<h2><strong>Speciality Field<\/strong><\/h2>\r\n<p>Division of Molecular Pathology<\/p>\r\n<h2><strong>Qualifications<\/strong><\/h2>\r\n<p>Board certified general thoracic surgeon and Councilor (The Japanese Association for Chest Surgery), Board certified surgeon (Japan Surgical society), Councilor (Nucleic Acids Therapeutics Society of Japan)<\/p>\r\n<h2><strong>Professional Experience<\/strong><\/h2>\r\n<table style=\"border-collapse: collapse; width: 100%; height: 144px;\">\r\n<tbody>\r\n<tr style=\"height: 48px;\">\r\n<td style=\"width: 19.0655%; height: 48px;\">2021.1-present<\/td>\r\n<td style=\"width: 80.9345%; height: 48px;\">Scientist, Division of Molecular Pathology at National Cancer Center Research Institute<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 19.0655%; height: 24px;\">2018.4-2020.12<\/td>\r\n<td style=\"width: 80.9345%; height: 24px;\">Research Fellow, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 19.0655%; height: 24px;\">2014.4-2018.3<\/td>\r\n<td style=\"width: 80.9345%; height: 24px;\">Assistant professor, Department of Thoracic Surgery, Kindai University Faculty of Medicine<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 19.0655%; height: 24px;\">2010.4-2014.3<\/td>\r\n<td style=\"width: 80.9345%; height: 24px;\">Resident\/ Senior resident, Department of Thoracic Surgery, Aichi Cancer Center<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 19.0655%; height: 24px;\">2008.4-2010.3<\/td>\r\n<td style=\"width: 80.9345%; height: 24px;\">Resident, Iizuka hospital<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>","researcher_outerlink1":"","researcher_outerlink2":"","researcher_outerlink3":"","researcher_outerlink4":"","researcher_outerlink5":"","is_retired":false},"_links":{"self":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher\/3524","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher"}],"about":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/types\/researcher"}],"acf:post":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/facility\/3398"}],"wp:attachment":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/media?parent=3524"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}